CeriBell, Inc.(CBLL) - 2025 Q3 - Quarterly Results

Ceribell Reports Third Quarter 2025 Financial Results SUNNYVALE, Calif., November 4, 2025 – CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the quarter ended September 30, 2025. Third Quarter 2025 & Recent Highlights "We are encouraged by our third quarter performance, which reflects strong commercial execution and continued momentum in adoption ...